3D microtumors in vitro supported by perfused vascular networks
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This "organs-on-chips" approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This "tumor-on-a-chip" platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumors and stromal cells (endothelial cells) coexisted in these microvessels networks for up to 24 days.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The tumors grew vigorously in the 3D extracellular matrix, depending for survival entirely on nutrient delivery through living, fully functional, and leak-free vasculature.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Remarkably, HCT116-cells growing in the vascularized microfluidic tumors exhibited chemoresistance to oxaliplatin that was one order higher than that shown by cells cultured in a 2D monolayer.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Specifically, this model allows for the creation of “vascularized micro-tumors” (VMTs), whereby the coculture of endothelial colony-forming cell-derived ECs, normal human lung fibroblasts and cancer cells under dynamic flow conditions enables the de novo formation of perfusable microvascular networks that surround the micro-tumors, supplying nutrients and therapeutics just as tumor-associated”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Sobrino et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The authors recreated, in a geometrically simple device (Figure 7e-i), a fully perfusable and complex vasculature network and was able to demonstrate the feasibility of culturing tumor spheroids for extended time periods.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sui, X., Kong, N., Wang, X., Fang, Y., Hu, X., Xu, Y., Chen, W., Wang, K., Li, D., Jin, W., et al. (2014) · Scientific Reports · doi:10.1038/srep04694 · Cited by 96
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
Miller, J. S., Stevens, K. R., Yang, M. T., Baker, B. M., Nguyen, D.-H. T., Cohen, D. M., Toro, E., Chen, A. A., Galie, P. A., Yu, X., et al. (2012) · Nature Materials · doi:10.1038/nmat3357 · Cited by 1,917
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
PDMS absorption of small molecules and consequences in microfluidic applications
Toepke, M. W., & Beebe, D. J. (2006) · Lab on a Chip · doi:10.1039/b612140c · Cited by 1,190
The Phasor Approach to Fluorescence Lifetime Imaging Analysis
Digman, M. A., Caiolfa, V. R., Zamai, M., & Gratton, E. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120154 · Cited by 1,145
Self-citationTargeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.60 · Cited by 989
In vitro microvessels for the study of angiogenesis and thrombosis
Zheng, Y., Chen, J., Craven, M., Choi, N. W., Totorica, S., Diaz-Santana, A., Kermani, P., Hempstead, B., Fischbach-Teschl, C., López, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201240109 · Cited by 894
Lin, S.-L., Kisseleva, T., Brenner, D. A., & Duffield, J. S. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080433 · Cited by 845
Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
Siolas, D., & Hannon, G. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1069 · Cited by 669
Vascular Targeting Agents as Cancer Therapeutics
Thorpe, P. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0642-03 · Cited by 577
Newman, A. C., Nakatsu, M. N., Chou, W., Gershon, P. D., & Hughes, C. C. W. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-05-0393 · Cited by 489
Self-citationWnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
Pate, K. T., Stringari, C., Sprowl‐Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., McQuade, M. M., Garner, C., Digman, M. A., Teitell, M. A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488598 · Cited by 459
Self-citationIntracellular Coenzymes as Natural Biomarkers for Metabolic Activities and Mitochondrial Anomalies
Heikal, A. A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.1 · Cited by 458
Stringari, C., Cinquin, A., Cinquin, O., Digman, M. A., Donovan, P. J., & Gratton, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108161108 · Cited by 427
Self-citationLongati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.-R., Rehnmark, S., Verbeke, C., Toftgård, R., Löhr, M., & Heuchel, R. L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-95 · Cited by 394
In Vitro Perfused Human Capillary Networks
Moya, M. L., Hsu, Y.-H., Lee, A. P., Hughes, C. C. W., & George, S. C. (2013) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0430 · Cited by 387
Self-citationSkala, M. C., Riching, K. M., Bird, D. K., Gendron-Fitzpatrick, A., Eickhoff, J., Eliceiri, K. W., Keely, P. J., & Ramanujam, N. (2007) · Journal of Biomedical Optics · doi:10.1117/1.2717503 · Cited by 380
Bird, D. K., Yan, L., Vrotsos, K. M., Eliceiri, K. W., Vaughan, E. M., Keely, P. J., White, J. G., & Ramanujam, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3922 · Cited by 372
Awada, A., Hendlisz, A., Gil, T., Bartholomeus, S., Mano, M., de Valeriola, D., Strumberg, D., Brendel, E., Haase, C. G., Schwartz, B., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602584 · Cited by 339
Tumor reversion: Correction of malignant behavior by microenvironmental cues
Kenny, P. A., & Bissell, M. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11491 · Cited by 326
Chapter 4 An Optimized Three‐Dimensional In Vitro Model for the Analysis of Angiogenesis
Nakatsu, M. N., & Hughes, C. C. W. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(08)02004-1 · Cited by 235
Self-citationJeon, J. S., Bersini, S., Whisler, J. A., Chen, M. B., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2014) · Integr. Biol. · doi:10.1039/c3ib40267c · Cited by 233
Selective Deposition of Proteins and Cells in Arrays of Microwells
Ostuni, E., Chen, C. S., Ingber, D. E., & Whitesides, G. M. (2001) · Langmuir · doi:10.1021/la001372o · Cited by 232
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor
Albert, D. H., Tapang, P., Magoc, T. J., Pease, L. J., Reuter, D. R., Wei, R.-Q., Li, J., Guo, J., Bousquet, P. F., Ghoreishi-Haack, N. S., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0410 · Cited by 207
Hsu, Y.-H., Moya, M. L., Hughes, C. C. W., George, S. C., & Lee, A. P. (2013) · Lab on a Chip · doi:10.1039/c3lc50424g · Cited by 192
Self-citationNon-invasive measurement of solute permeability in cerebral microvessels of the rat
Yuan, W., Lv, Y., Zeng, M., & Fu, B. M. (2009) · Microvascular Research · doi:10.1016/j.mvr.2008.08.004 · Cited by 175
Chitcholtan, K., Asselin, E., Parent, S., Sykes, P. H., & Evans, J. J. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.09.012 · Cited by 173
Baguley, B. C., Holdaway, K. M., Thomsen, L. L., Zhuang, L., & Jonathan Zwi, L. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90391-p · Cited by 172
Functional Vascular Endothelium Derived from Human Induced Pluripotent Stem Cells
Adams, W. J., Zhang, Y., Cloutier, J., Kuchimanchi, P., Newton, G., Sehrawat, S., Aird, W. C., Mayadas, T. N., Luscinskas, F. W., & García-Cardeña, G. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.06.007 · Cited by 168
Cancer cell spheroids as a model to evaluate chemotherapy protocols
Perche, F., & Torchilin, V. P. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21353 · Cited by 163
Bagley, R. G., Walter-Yohrling, J., Cao, X., Weber, W. D., Simons, B., Cook, B. P., Chartrand, S., Wang, C., Madden, S. L., & Teicher, B. A. (2003) · PubMed · Cited by 143
Sacharidou, A., Koh, W., Stratman, A. N., Mayo, A. M., Fisher, K. E., & Davis, G. E. (2010) · Blood · doi:10.1182/blood-2009-11-252692 · Cited by 140
Full range physiological mass transport control in 3D tissue cultures
Hsu, Y.-H., Moya, M. L., Abiri, P., Hughes, C. C. W., George, S. C., & Lee, A. P. (2013) · Lab Chip · doi:10.1039/c2lc40787f · Cited by 124
Self-citationEnergy disruptors: rising stars in anticancer therapy?
Bost, F., Decoux-Poullot, A.-G., Tanti, J. F., & Clavel, S. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.46 · Cited by 115
Wang, H.-W., Ghukasyan, V., Chen, C.-T., Wei, Y., Guo, H.-W., Yu, J.-S., & Kao, F. (2008) · Journal of Biomedical Optics · doi:10.1117/1.2975831 · Cited by 114
Aljitawi, O. S., Li, D., Xiao, Y., Zhang, D., Ramachandran, K., Stehno-Bittel, L., Van Veldhuizen, P., Lin, T. L., Kambhampati, S., & Garimella, R. (2014) · Leukemia & Lymphoma · doi:10.3109/10428194.2013.793323 · Cited by 112
Imaging metabolic heterogeneity in cancer
Sengupta, D., & Pratx, G. (2016) · Molecular Cancer · doi:10.1186/s12943-015-0481-3 · Cited by 98
Chimote, G., Sreenivasan, J., Pawar, N., Subramanian, J., Sharma, S., & Sivaramakrishnan, H. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s55621 · Cited by 81
Peters, K., Kamp, G., Berz, A., Unger, R. E., Barth, S., Salamon, A., Rychly, J., & Kirkpatrick, C. J. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000257490 · Cited by 78
The Cultural Divide: Exponential Growth in Classical 2D and Metabolic Equilibrium in 3D Environments
Wrzesinski, K., Rogowska-Wrzesinska, A., Kanlaya, R., Borkowski, K., Schwämmle, V., Dai, J., Joensen, K. E., Wojdyla, K., Carvalho, V. B., & Fey, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106973 · Cited by 77
Endothelial cell metabolism and implications for cancer therapy
Harjes, U., Bensaad, K., & Harris, A. L. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.398 · Cited by 72
Reese, J. M., Suman, V. J., Subramaniam, M., Wu, X., Negron, V. C., Gingery, A., Pitel, K. S., Shah, S., Cunliffe, H. E., McCullough, A. E., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-749 · Cited by 71
Epigenetic and Phenotypic Profile of Fibroblasts Derived from Induced Pluripotent Stem Cells
Hewitt, K. J., Shamis, Y., Hayman, R. B., Margvelashvili, M., Dong, S., Carlson, M. W., & Garlick, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017128 · Cited by 59
Seaman, M. E., Peirce, S. M., & Kelly, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020807 · Cited by 57
Santini, M. T., Rainaldi, G., Romano, R., Ferrante, A., Clemente, S., Motta, A., & Indovina, P. L. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01466-2 · Cited by 56
Heylman, C., Sobrino, A., Shirure, V. S., Hughes, C. C., & George, S. C. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214525295 · Cited by 53
Self-citationLife is Three Dimensional—As In Vitro Cancer Cultures Should Be
Levinger, I., Ventura, Y., & Vago, R. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00009-3 · Cited by 49
Berthod, F., Symes, J., Tremblay, N. M., Medin, J. A., & Auger, F. A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22943 · Cited by 42
Current status of antiangiogenic therapies for glioblastomas
Arrillaga‐Romany, I., Reardon, D. A., & Wen, P. Y. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.856880 · Cited by 34
A deep tissue fluorescence imaging system with enhanced SHG detection capabilities
Crosignani, V., Jahid, S., Dvornikov, A. S., & Gratton, E. (2014) · Microscopy Research and Technique · doi:10.1002/jemt.22354 · Cited by 28
Self-citationAntiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities
Ferrarotto, R., & Hoff, P. M. (2012) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2012.06.002 · Cited by 21
Cited by
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487
Self-citationOrgan-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Metadata
- Authors
- Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W.
- Affiliations
- University of California, Irvine (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hughes, Christopher C. W.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-08-23
- Volume
- 6
- Issue
- 1
- Pages
- 31589-31589
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4994029
- OpenAlex
- W2510834891
- Cited by
- 387
- References
- 58
- Citations by year
- 2026: 23 · 2025: 34 · 2024: 41 · 2023: 36 · 2022: 52 · 2021: 56 · 2020: 52 · 2019: 29 · 2018: 35 · 2017: 28 · 2016: 1
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Coordinating Council for Women in History
- National Institutes of Health (UH3TR000481, UL1TR001414, UH2TR000481)
- National Cancer Institute (R01CA170879, P30A062203, R01CA180122)
- National Center for Advancing Translational Sciences
- Chao Family Comprehensive Cancer Center (P30A062203)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor-on-a-chip, 3D extracellular matrix, colorectal cancer, breast cancer, tumor stroma, vascular targeting agents, VEGFR inhibitors, PDGFR inhibitors, metabolic heterogeneity, aerobic glycolysis, drug response
- MeSH terms
- Breast Neoplasms, Female, Humans, Male, Models, Biological, Neovascularization, Pathologic, Colorectal Neoplasms, Angiogenesis Inhibitors, Microfluidic Analytical Techniques, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.